OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure

HTML

Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Circulation
DOI: 10.1161/01.cir.0000014212.04920.62
Authors: Karl Swedberg, Michael R. Bristow, Jay N. Cohn, Henry Dargie, Matthias Straub, Curtis Wiltse, Theressa J. Wright
Institutions: Eli Lilly (United States), Sahlgrenska University Hospital, University of Colorado Hospital, University of Colorado Health, University of Minnesota, University of Glasgow, Solvay (Germany)
Language: English

Topic: Heart Failure Treatment and Management
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: moxonidine, sustained-release formulation, chronic heart failure, plasma norepinephrine, sympathetic activation, imidazoline agonists, dose-response relationship, left ventricular ejection fraction, heart rate, adverse events, reverse remodeling
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2026377786
FWCI: 7.046
Cites: 22
Cited by: 109
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security